Meanwhile, the authors’ previous results provide preliminary evidence that tanshinone IIA exerts an inhibitory effect on IL-17A-induced proliferation, collagen synthesis, and migration of SSc patient-derived DVSMCs. The gene discussed is IL17A; the disease is systemic sclerosis.